Cash & equivalents decreased 19.3%
Cash & equivalents changed -19.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -19.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed -27.2% from the comparable as-filed period.
Inventory / revenue changed -534 basis points from the comparable as-filed period.
SBC / revenue changed +252 basis points from the comparable as-filed period.
Working capital changed +15.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross debt changed +19.3% from the comparable as-filed period. The change ranks at the 33th percentile of 9 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Reported total debt changed +19.3% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Net debt changed +25.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash / debt changed -450 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +51.2% from the comparable as-filed period.
Free-cash-flow margin changed -3792 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1719 basis points from the comparable as-filed period.
Receivables / revenue changed -494 basis points from the comparable as-filed period.
Revenue changed -4.0% from the comparable as-filed period.
Debt / revenue changed +9871 basis points from the comparable as-filed period.
Total assets changed -7.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed +9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -5.5% from the comparable as-filed period.
R&D / revenue changed -8 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.